Our own Thatcher Heumann @VUMC_Cancer will be presenting at 10:27am today @#rapidabstractsession on ABS#4017 Randomized Phase 2 of atezo/CDX-1127+/ cobimetinib in met #biliarycancer. #ASCO24 @asco Vanderbilt University Medical Center AHPBA

⁦Reena Jayani-Kosarzycki⁩ discusses the ⁦Vanderbilt University Medical Center⁩ approach to older adults needing transplant…#makinghealthcarepersonal #geriatriconcology ⁦Vanderbilt Health⁩ ⁦@VUMCHemOnc⁩ ⁦@VUMC_Cancer⁩

.Vanderbilt Health researchers are touting data from a multicenter, international phase 2 clinical trial showing a new, curative treatment for #sicklecelldisease. Results from the 10-year trial were recently published in @BloodJournal. bit.ly/4cCbzX2

Emotion regulation is like other skills: it takes practice. After 2 weeks of daily journaling to reframe unpleasant events, depression dropped, life satisfaction rose, and the benefits lasted at least a month. The best way to improve at managing emotions is to do it more often.

Looking forward to presenting our EA2201 data at #ESMOGI24 today! Vanderbilt University Medical Center @VUMCHemOnc @NCICTEP_ClinRes ECOG-ACRIN Cancer Research Group

👏 GREAT job Kristen Ciombor interim of MULTI-site #EA2201 ECOG-ACRIN Cancer Research Group @NCICTEP_ClinRes MSI-H #rectalcancer re: role of Nivo/ipi + 5x5 XRT/TME. Similar cCR + pCR to some prior studies. Next steps: 🤔 Best duration? Combo IO? More to follow ➡️ amendment! @VUMC_Cancer ESMO - Eur. Oncology

FASCO24 Designation Recipients ASCO Laura Goff Sharlene Gill, MD, MPH, MBA, FASCO Thomas George, MD, FACP, FASCO Memorial Sloan Kettering Cancer Center Alex Spira, M.D. Robert Haddad Ghassan Abou-Alfa Kevin Kalinsky, MD, MS, FASCO H. Jack West, MD, FASCO Herbert Loong, MBBS, FASCO Josep Tabernero Rana McKay, MD, FASCO Edgardo S. Santos, M.D., FACP, FASCO Phil Kantoff Gladys Rodriguez,MD, FASCO Frederick Chite MD FASCO Ishwaria Subbiah, MD MS FASCO Ana I. Velázquez Mañana, MD, MSc, FASCO

Laura W. Goff, MD, MSCI, MMHC, discusses the onslaught of treatment sequencing available in gastrointestinal cancer. #gicsm | Laura Goff cancernetwork.com/view/an-embarr…

Download and SHARE the one-pager and learn more about how clinical trials can provide hope and help the cancer community take a bigger step toward cures.

My favorite workday of the year #flulapalooza Vanderbilt University Medical Center @VUMCHemOnc

The BEST mentor/sponsor 😊

Very timely keynote from Pamela Kunz, MD, FASCO at #GI25 about the need for inclusive excellence in our workforce

Is 2025 going to be the year Pan-RAS inhibitors make it into the clinic? Pan-RAS inhibitor shows early/deep molecular response (and 36% response rate) for G12X mutated pancreatic cancer. (Significant AEs: rash, diarrhea, nausea, vomiting) dailynews.ascopubs.org/do/pan-ras-inh…

So you've heard the practice changing exercise CHALLENGE trial! But what did that groundbreaking exercise program actually look like day-to-day? Let's explore the "Structured Exercise Program" based on info from their paper supplement on NEJM #ASCO2025 #ASCO25 1/10

Highly recommend the entire session but in particular the talk by Katie Coleman about WHAT to do to better care for early onset patients Kimryn Rathmell Dr. Cathy Eng #ASCO25

It was so wonderful to be able to participate in this @asco #asco25 session "Beyond the headlines: The Real Impact of Early-Onset Cancers". Kimryn Rathmell Katie Coleman and Drs. LeeAnne Bailey + Andrew Chang NCICancerTrials Mass General #cancer #earlyonset #cancerresearch